In 2023, sales of Genito Urinary System and Sex Hormones in Italy stood at $656 million PPP. The forecast from 2024 to 2028 shows a slight but steady increase, with values rising from $656.5 million PPP in 2024 to $658.5 million PPP in 2028. This indicates a stable market with minimal fluctuation and a consistent year-on-year increase of around 0.1% to 0.2%, revealing a slow growth trend.

Future trends to watch for:

Technological advancements in drug development, potentially increasing market share for innovative treatments.
Regulatory changes or healthcare reforms that might impact pricing and availability.
Demographic shifts, such as aging populations, which may increase demand for these medications.
Increased focus on personalized medicine could drive market changes.